Life-extending prostate drug is ruled out for NHS use as officials deem it's not worth the money

The National Institute for Health and Care Excellence (Nice) said evidence on the benefits of olaparib is uncertain and approving it would not be a good use of NHS funds.

from Health News | Mail Online https://ift.tt/3JGiMYm